New Haven (1)

Advanced Treatment-Naive PD-L1 (1)

Carcinoma, Non-Small-Cell Lung (1)

Lung Diseases (1)

Lung Neoplasms (1)

Metastatic Lung Non-Small Cell Carcinoma (1)

PD-L1 Gene Mutation (1)

Pembrolizumab (1)

Sitravatinib (1)

Stage IV Lung Non-Small Cell Cancer AJCC v7 (1)

Recruiting (1)

phase 2 (1)

Sarah Goldberg (1)

Mirati Therapeutics Inc. (1)

pembrolizumab (1)

sitravatinib (1)

drug (1)

Other (1)

Interventional (1)

Advanced Treatment-Naive PD-L1

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Oct 26, 2022